Evolva Holding SA (EVE.SW)

CHF 0.84

(-6.44%)

Total Liabilities Summary of Evolva Holding SA

Evolva Holding SA's latest annual total liabilities in 2023 was 4.27 Million CHF , down -82.74% from previous year.
Evolva Holding SA's latest quarterly total liabilities in 2024 Q2 was 893.5 Thousand CHF , down 0.0% from previous quarter.
Evolva Holding SA reported annual total liabilities of 24.76 Million CHF in 2022, up 1.5% from previous year.
Evolva Holding SA reported annual total liabilities of 24.4 Million CHF in 2021, up 11.94% from previous year.
Evolva Holding SA reported quarterly total liabilities of 2.69 Million CHF for 2023 FY, down -89.11% from previous quarter.
Evolva Holding SA reported quarterly total liabilities of 4.27 Million CHF for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Evolva Holding SA (2023 - 2005)

Historical Annual Total Liabilities of Evolva Holding SA (2023 - 2005)

Year	Total Liabilities	Total Liabilities Growth
2023	4.27 Million CHF	-82.74%
2022	24.76 Million CHF	1.5%
2021	24.4 Million CHF	11.94%
2020	21.8 Million CHF	11.71%
2019	19.51 Million CHF	3.5%
2018	18.85 Million CHF	-1.29%
2017	19.1 Million CHF	-24.14%
2016	25.17 Million CHF	-12.64%
2015	28.82 Million CHF	-23.38%
2014	37.61 Million CHF	71.06%
2013	21.99 Million CHF	-24.52%
2012	29.13 Million CHF	-12.44%
2011	33.27 Million CHF	50.87%
2010	22.05 Million CHF	-11.65%
2009	24.96 Million CHF	10.98%
2008	22.49 Million CHF	15.9%
2007	19.4 Million CHF	6.18%
2006	18.27 Million CHF	282.79%
2005	4.77 Million CHF	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	893.5 Thousand CHF	0.0%
2023 FY	2.69 Million CHF	-89.11%
2023 Q4	4.27 Million CHF	0.0%
2023 Q2	24.32 Million CHF	0.0%
2022 Q4	24.76 Million CHF	0.0%
2022 Q2	25.77 Million CHF	0.0%
2022 FY	24.76 Million CHF	1.5%
2021 Q4	24.4 Million CHF	0.0%
2021 Q2	28.17 Million CHF	0.0%
2021 FY	24.4 Million CHF	11.94%
2020 FY	21.8 Million CHF	11.71%
2020 Q2	18.69 Million CHF	0.0%
2020 Q4	21.8 Million CHF	0.0%
2019 Q2	17.69 Million CHF	0.0%
2019 FY	19.51 Million CHF	3.5%
2019 Q4	19.51 Million CHF	0.0%
2018 Q2	26.32 Million CHF	0.0%
2018 Q4	18.85 Million CHF	0.0%
2018 FY	18.85 Million CHF	-1.29%
2017 FY	19.1 Million CHF	-24.14%
2017 Q4	19.1 Million CHF	0.0%
2017 Q2	22.39 Million CHF	0.0%
2016 Q4	25.17 Million CHF	0.0%
2016 Q2	28.01 Million CHF	0.0%
2016 FY	25.17 Million CHF	-12.64%
2015 Q4	28.82 Million CHF	0.0%
2015 FY	28.82 Million CHF	-23.38%
2015 Q2	34.29 Million CHF	0.0%
2014 FY	37.61 Million CHF	71.06%
2014 Q2	20.89 Million CHF	0.0%
2014 Q4	37.61 Million CHF	0.0%
2013 Q4	21.99 Million CHF	0.0%
2013 Q2	26.27 Million CHF	0.0%
2013 FY	21.99 Million CHF	-24.52%
2012 Q2	32.07 Million CHF	0.0%
2012 Q4	29.13 Million CHF	0.0%
2012 FY	29.13 Million CHF	-12.44%
2011 Q4	33.27 Million CHF	0.0%
2011 FY	33.27 Million CHF	50.87%
2011 Q2	19.33 Million CHF	0.0%
2010 Q2	23.57 Million CHF	0.0%
2010 FY	22.05 Million CHF	-11.65%
2010 Q4	22.05 Million CHF	0.0%
2009 Q4	24.96 Million CHF	0.0%
2009 FY	24.96 Million CHF	10.98%
2008 FY	22.49 Million CHF	15.9%
2007 FY	19.4 Million CHF	6.18%
2006 FY	18.27 Million CHF	282.79%
2005 FY	4.77 Million CHF	0.0%

Peer Total Liabilities Comparison of Evolva Holding SA

Name	Total Liabilities	Total Liabilities Difference
Addex Therapeutics Ltd	3.49 Million CHF	-22.285%
BB Biotech AG	304.9 Million CHF	98.598%
Basilea Pharmaceutica AG	183.29 Million CHF	97.667%
Idorsia Ltd	1.46 Billion CHF	99.709%
Kuros Biosciences AG	19.19 Million CHF	77.724%
Molecular Partners AG	21.92 Million CHF	80.497%
Relief Therapeutics Holding AG	24.16 Million CHF	82.304%
Santhera Pharmaceuticals Holding AG	49.68 Million CHF	91.395%